Publication | Open Access

Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients

MedicineT-regulatory CellImmunologyMetronomic Cyclophosphamide RegimenAutoimmunityRestores TCell BiologyMetronomic ChemotherapyImmunotherapyOncologyCell TransplantationTumor MicroenvironmentNk Effector Functions